Allmed Medical Products Co.,Ltd (SHE:002950)

SHE:002950 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	890.24	585.16	397.04	522.2	678.46	1,302
Short-Term Investments	-	-	2.14	-	-	200
Trading Asset Securities	2.11	83.15	96.82	264.63	8.14	35.63
Cash & Short-Term Investments	892.35	668.32	496	786.84	686.6	1,538
Cash Growth	61.83%	34.74%	-36.96%	14.60%	-55.35%	531.34%
Accounts Receivable	442.01	482.75	391.25	521.56	532.46	295.55
Other Receivables	77.23	72.76	68.01	47.38	56.58	51.75
Receivables	519.24	555.51	459.26	568.94	589.04	347.3
Inventory	599.37	615.27	707.21	877.33	846.63	707.28
Other Current Assets	117.18	88.72	117.08	165.85	120.83	243.85
Total Current Assets	2,128	1,928	1,780	2,399	2,243	2,836
Property, Plant & Equipment	1,794	1,829	1,988	2,019	1,603	1,259
Long-Term Investments	852.93	854.48	854.89	824.79	758.68	403.24
Goodwill	95.3	95.3	98.09	98.09	25.99	-
Other Intangible Assets	179.18	182.78	202.66	213.58	234.75	219.53
Long-Term Accounts Receivable	-	-	-	-	17.05	18.76
Long-Term Deferred Tax Assets	46.26	49.14	56.19	48.88	64	44.14
Long-Term Deferred Charges	6.36	6.76	7.08	4.74	1.14	1.26
Other Long-Term Assets	124.63	113.27	97.39	139.79	57.01	68.85
Total Assets	5,227	5,059	5,084	5,748	5,005	4,856
Accounts Payable	327.56	360.87	326.1	897.32	253.86	143.87
Accrued Expenses	92.61	90.01	76.39	84.96	79.82	73.7
Short-Term Debt	553.44	494.31	749.57	792.09	1,060	1,086
Current Portion of Long-Term Debt	76.17	69.11	54.2	27.15	99.09	-
Current Portion of Leases	-	7.68	6.36	2.1	2.27	-
Current Income Taxes Payable	33.45	24.54	6.29	4.93	35.28	85.78
Current Unearned Revenue	45.44	13.02	64.84	129.32	7.8	52.48
Other Current Liabilities	39.62	48.2	41.7	129.06	100.91	23.44
Total Current Liabilities	1,168	1,108	1,325	2,067	1,639	1,465
Long-Term Debt	109.41	89.17	146.32	111.41	127.61	100
Long-Term Leases	0.04	0.43	4.61	5.37	0.6	-
Long-Term Unearned Revenue	193.23	197.51	191.94	189.68	292.17	220.45
Long-Term Deferred Tax Liabilities	230	216.04	199.71	243.16	193.82	147.28
Other Long-Term Liabilities	-	-	5.32	-	-	-
Total Liabilities	1,701	1,611	1,873	2,617	2,253	1,933
Common Stock	633.27	633.27	633.27	633.27	633.27	633.27
Additional Paid-In Capital	580.21	580.21	565.77	565.77	564.49	572.56
Retained Earnings	2,398	2,312	1,960	1,888	1,619	1,745
Treasury Stock	-107.03	-97.89	-	-	-	-
Comprehensive Income & Other	9.61	8.96	28.1	14.32	-63.63	-40.15
Total Common Equity	3,515	3,437	3,187	3,101	2,753	2,911
Minority Interest	11.66	11.51	23.73	29.91	-0.91	12.41
Shareholders' Equity	3,526	3,448	3,211	3,131	2,752	2,923
Total Liabilities & Equity	5,227	5,059	5,084	5,748	5,005	4,856
Total Debt	739.06	660.7	961.06	938.13	1,289	1,186
Net Cash (Debt)	153.29	7.62	-465.06	-151.29	-602.53	351.86
Net Cash Per Share	0.25	0.01	-0.73	-0.24	-0.95	0.56
Filing Date Shares Outstanding	633.26	618.76	621.92	633.27	633.27	633.27
Total Common Shares Outstanding	633.26	618.76	633.27	633.27	633.27	633.27
Working Capital	959.86	820.08	454.08	332.03	604.51	1,371
Book Value Per Share	5.55	5.55	5.03	4.90	4.35	4.60
Tangible Book Value	3,240	3,158	2,886	2,789	2,492	2,691
Tangible Book Value Per Share	5.12	5.10	4.56	4.40	3.94	4.25
Buildings	-	1,197	1,220	1,044	989.99	814.48
Machinery	-	1,879	2,044	1,679	1,534	1,120
Construction In Progress	-	27	18.35	400.62	38.24	72.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.